Showing results (211-220 of 397) with videos related to
Sort By:
Pageof 40
Immunology Letters|January 1, 1982
Isolation and characterization of the C3b-binding entity of C3b-receptor from human erythrocytesH H Mussel, T Ehlen, M Schmitt, et al.Zeitschrift Fur Gastroenterologie|June 1, 1993
Vero cytotoxin-producing Escherichia coli O157 infections in AustriaB Sölder, F Allerberger, A Eigentler, et al.Experimental and Clinical Immunogenetics|January 1, 1996
Temperature-dependent surface expression of the beta-2-integrin analogue of Candida albicans and its role in adhesion to the human endotheliumR Würzner, M Langgartner, L Spötl, et al.Immunology Letters|September 11, 1999
Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45Y H Chen, W Wu, J Yang, et al.Immunology|June 1, 1995
Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1Z Prohászka, T Hidvégi, E Ujhelyi, et al.European Journal of Immunology|September 1, 1994
Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts: a possible model for its co-distribution with the IL-2 receptor, class I and class II HLA moleculesL Bene, M Balázs, J Matkó, et al.International Archives of Allergy and Applied Immunology|January 1, 1982
A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cellsO Scheiner, K P Hammann, H U Schmid, et al.Behring Institute Mitteilungen|December 1, 1993
Interaction of C1 with HIV-1N M Thielens, I M Bally, C F Ebenbichler, et al.Immunology Letters|August 30, 2000
Human interferon-beta inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41T Yu, Y Xiao, Y Bai, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1N M Thielens, I M Bally, C F Ebenbichler, et al.Pageof 40